Anticuerpos contra el virus de la estomatitis vesicularen sajinos (Tayassu tajacu) de zoocriaderos de Iquitos y Pucallpa

Wilson D., Aldo; Araínga Ramírez, Mariluz Anamelva; Gálvez Carrillo, Hugo Alejandro; Manchego Sayan, Alberto Gustavo; Rivera Gerónimo, Hermelinda.
Rev. investig. vet. Perú (Online) ; 16(2): 180-183, ene-dic. 2005.
Artículo en Español | LIPECS | ID: biblio-1110613

Documentos relacionados

  1. Protective Efficacy of Lyophilized Vesicular Stomatitis Virus-Based Vaccines in Animal Model.
  2. Preexisting Immunity Does Not Prevent Efficacy of Vesicular Stomatitis Virus-Based Filovirus Vaccines in Nonhuman Primates.
  3. A Recombinant Vesicular Stomatitis Virus-Based Vaccine Provides Postexposure Protection Against Bundibugyo Ebolavirus Infection.
  4. Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential.
  5. Interferon-induced protein Ifit2 protects mice from infection of the peripheral nervous system by vesicular stomatitis virus.
  6. Recombinant adenovirus expressing vesicular stomatitis virus G proteins induce both humoral and cell-mediated immune responses in mice and goats.
  7. Efficacy of Vesicular Stomatitis Virus-Ebola Virus Postexposure Treatment in Rhesus Macaques Infected With Ebola Virus Makona.
  8. SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern.
  9. Nuclear RNF2 inhibits interferon function by promoting K33-linked STAT1 disassociation from DNA.
  10. A single nucleotide polymorphism of porcine MX2 gene provides antiviral activity against vesicular stomatitis virus.